{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T23:42:55Z","timestamp":1791416575595,"version":"4.3.3"},"reference-count":71,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"14","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCO"],"published-print":{"date-parts":[[2005,5,10]]},"abstract":"<jats:p> The treatment of stage III non\u2013small-cell lung cancer has evolved over the last two decades, with combined-modality therapy the current standard of care. As a result, intermediate and long-term survival has improved for patients in this common stage category, compared to the poor outcomes achieved with the historical standard of once-daily radiation therapy alone. This review summarizes two decades of clinical research regarding bimodality and trimodality approaches for the heterogenous stage subsets within the stage III designation, discusses the rationale and status of prophylactic brain irradiation, and concludes with perspectives on progress and future directions. Chemotherapy plus radiotherapy given concurrently is the optimal treatment for the group of patients with advanced stage III disease. The potential role of a surgical resection following chemotherapy (with or without radiation) in this setting is still controversial. The only subsets for which trimodality treatments are clearly preferred include T4N0-1 disease and superior sulcus tumors. The other major stage III subgroup has a minimal disease burden with low tumor volume and\/or microscopic N2 disease, thus technically could undergo a surgical resection upfront. Induction chemotherapy before surgery may yield a survival advantage, although the phase III trials in this area are not conclusive. Given the marked survival benefit from adjuvant chemotherapy after surgery in even earlier stages of non\u2013small-cell lung cancer, the proper sequence of surgery and chemotherapy (before v after surgery) remains an important unresolved question in this subgroup. Furthermore, how to incorporate radiation therapy, as well as whether it should be given at all in this subset of patients, are other important issues actively under study in ongoing trials. <\/jats:p>","DOI":"10.1200\/jco.2005.03.008","type":"journal-article","created":{"date-parts":[[2005,5,10]],"date-time":"2005-05-10T17:03:13Z","timestamp":1115744593000},"page":"3257-3269","source":"Crossref","is-referenced-by-count":94,"title":["Multimodality Therapy for Stage III Non\u2013Small-Cell Lung Cancer"],"prefix":"10.1200","volume":"23","author":[{"given":"Daniel","family":"Farray","sequence":"first","affiliation":[{"name":"From the Loyola University Chicago Medical Center, Maywood, IL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nena","family":"Mirkovic","sequence":"additional","affiliation":[{"name":"From the Loyola University Chicago Medical Center, Maywood, IL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathy S.","family":"Albain","sequence":"additional","affiliation":[{"name":"From the Loyola University Chicago Medical Center, Maywood, IL"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"233","reference":[{"key":"BIB1","doi-asserted-by":"crossref","unstructured":"Andre F, Grunenwald D, Pignon JP, et al: Survival of patients with resected N2 non-small-cell lung cancer: Evidence for a subclassification and implications. J Clin Oncol 18:2981,2001-2989,","DOI":"10.1200\/JCO.2000.18.16.2981"},{"key":"BIB2","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-198309000-00015"},{"key":"BIB3","doi-asserted-by":"crossref","unstructured":"Pearson FG, DeLarue NC, Ilves R, et al: Significance of positive superior mediastinal nodes identified at mediastinoscopy in patients with resectable cancer of the lung. J Thorac Cardiovasc Surg 83:1,1982-11,","DOI":"10.1016\/S0022-5223(19)37318-0"},{"key":"BIB4","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/88.17.1210"},{"key":"BIB5","doi-asserted-by":"publisher","DOI":"10.1378\/chest.117.2.358"},{"key":"BIB6","doi-asserted-by":"publisher","DOI":"10.1016\/0169-5002(94)91687-X"},{"key":"BIB7","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1999.17.9.2692"},{"key":"BIB8","unstructured":"Pierre F, Perol M, Gilles R, et al: A randomized phase III trial of sequential chemo-radiotherapy versus concurrent chemo-radiotherapy in locally advanced non small cell lung cancer (GLOT-GFPC NPC 95-01 study). Proc Am Soc Clin Oncol 20: 312a,2001,  (abstr 1246)"},{"key":"BIB9","unstructured":"Curran WJ, Scott CB, Langer CJ, et al: Long-term benefit is observed in a phase III comparison of sequential versus concurrent chemo-radiation for patients with unresected stage III nsclc: RTOG 9410. Proc Am Soc Clin Oncol 22:621,2003,  (abstr 2499)"},{"key":"BIB10","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2004.03.004"},{"key":"BIB11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199202203260805"},{"key":"BIB12","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.03.055"},{"key":"BIB13","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.04.197"},{"key":"BIB14","doi-asserted-by":"publisher","DOI":"10.1097\/00000421-199204000-00014"},{"key":"BIB15","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.03.054"},{"key":"BIB16","unstructured":"Choy H, Curran WJ, Scott CB, et al: Preliminary report of locally advanced multimodality protocol (LAMP): ACR 427: A randomized phase II study of three chemo-radiation regimens with paclitaxel, carboplatin, and thoracic radiation for patients with locally advanced non small cell lung cancer. Proc Am Soc Clin Oncol 21:291,2002,  (abstr 1160)"},{"key":"BIB17","doi-asserted-by":"crossref","unstructured":"Huber RM, Scmidt M, Flentje M et al: Induction chemotherapy and following simultaneous radio\/chemotherapy versus induction chemotherapy and radiotherapy alone in inoperable NSCLC (stage IIIA\/IIIB). Proc Am Soc Clin Oncol 22:622,2003,  (abstr 2501)","DOI":"10.1200\/jco.2004.22.90140.7075"},{"key":"BIB18","doi-asserted-by":"crossref","unstructured":"Vokes EE, Hemdon JE, Kelley MJ, et al: Induction chemotherapy followed by concomitant chemoradiotherapy versus chemoradiotherapy alone for regionally advanced unresectable non-small cell lung cancer: initial analysis of a randomized phase III trial. J Clin Oncol 22:14S,2004,  (suppl; abstr 7005)","DOI":"10.1200\/jco.2004.22.90140.7005"},{"key":"BIB19","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.03.022"},{"key":"BIB20","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197509)36:3<914::AID-CNCR2820360312>3.0.CO;2-Q"},{"key":"BIB21","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/86.9.673"},{"key":"BIB22","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199401203300301"},{"key":"BIB23","doi-asserted-by":"publisher","DOI":"10.1016\/0003-4975(92)90373-C"},{"key":"BIB24","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2002.20.1.247"},{"key":"BIB25","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5223(00)70120-6"},{"key":"BIB26","unstructured":"Pisters KM, Ginsberg RJ, Giroux DJ, et al: Bimodality Lung Oncology Team (BLOT) trial of induction paclitaxel\/carboplatin in early stage non-small cell lung cancer (NSCLC): Long term followup of a phase II trial. Proc Am Soc Clin Oncol 22:633,2003,  (abstr 2544)"},{"key":"BIB27","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.11.040"},{"key":"BIB28","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11662"},{"key":"BIB29","doi-asserted-by":"publisher","DOI":"10.3816\/CLC.2000.n.020"},{"key":"BIB30","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.14.2658"},{"key":"BIB31","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(03)00319-8"},{"key":"BIB32","doi-asserted-by":"crossref","unstructured":"Manegold C, Biesma B, Smit H, et al: Docetaxel and cisplatin as induction chemotherapy in stage IIIA N2 non-small cell lung cancer (NSCLC): An EORTC phase II trial (08984). J Clin Oncol 22:14S,2004,  (suppl; abstr 7166)","DOI":"10.1200\/jco.2004.22.90140.7166"},{"key":"BIB33","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11460"},{"key":"BIB34","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa031644"},{"key":"BIB35","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa032792"},{"key":"BIB36","doi-asserted-by":"crossref","unstructured":"Winton TL, Livingston R: Johnson D, et al: A prospective randomised trial of adjuvant vinorelbine (VIN) and cisplatin (CIS) in completely resected stage 1B and II non small cell lung cancer (NSCLC) Intergroup JBR.10. J Clin Oncol 22:14S,2004,  (suppl; abstr 7018)","DOI":"10.1200\/jco.2004.22.90140.7018"},{"key":"BIB37","doi-asserted-by":"crossref","unstructured":"Strauss GM, Herndon J, Maddaus MA, et al: Randomized clinical trial of adjuvant chemotherapy with paclitaxel and carboplatin following resection in stage IB non-small cell lung cancer (NSCLC): Report of Cancer and Leukemia Group B (CALGB) Protocol 9633. J Clin Oncol 22:14S,2004,  (suppl; abstr 7019)","DOI":"10.1200\/jco.2004.22.90140.7019"},{"key":"BIB38","doi-asserted-by":"publisher","DOI":"10.1016\/S0169-5002(03)00300-3"},{"key":"BIB39","doi-asserted-by":"crossref","unstructured":"Albain KS, Scott CB, Rusch VR, et al: Phase III comparison of concurrent chemotherapy plus radiotherapy (CT\/radiotherapy) and CT\/radiotherapy followed by surgical resection for stage IIIA(pN2) non-small cell lung cancer (NSCLC): Initial results from Intergroup trial 0139 (RTOG 93-09). Proc Am Soc Clin Oncol 22:621,2003,  (abstr 2497)","DOI":"10.1016\/S0169-5002(03)91657-6"},{"key":"BIB40","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1995.13.8.1880"},{"key":"BIB41","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2004.02.003"},{"key":"BIB42","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6601624"},{"key":"BIB43","unstructured":"Eberhardt W, Le Pechoux C, Gauler T: Multicenter German\/French phase-II trial of induction chemotherapy (CTx) followed by hyperfractionated accelerated thoracic radiotherapy concurrent with CTx +\/\u2212 surgery in locally advanced inoperable non-small-cell lung cancer stage III patients\u2014Mature results of a novel induction CTx regimen. Lung Cancer 46:S40,2004-S41,"},{"key":"BIB44","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(20001101)89:9<1946::AID-CNCR10>3.0.CO;2-1"},{"key":"BIB45","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(93)90371-2"},{"key":"BIB46","doi-asserted-by":"publisher","DOI":"10.1016\/S0169-5002(03)00078-3"},{"key":"BIB48","doi-asserted-by":"crossref","unstructured":"Shaw RR, Paulson DL, Kee JL Jr: Treatment of the superior sulcus tumor by irradiation followed by resection. Ann Surg 7:29,1961-40,","DOI":"10.1097\/00000658-196107000-00003"},{"key":"BIB49","doi-asserted-by":"publisher","DOI":"10.1067\/mtc.2000.106089"},{"key":"BIB50","doi-asserted-by":"publisher","DOI":"10.1067\/mtc.2001.112465"},{"key":"BIB51","unstructured":"Rusch VW, Giroux DJ, Kraut MJ, et al: Induction chemoradiation and surgical resection for non-small cell lung carcinomas of the superior sulcus: Mature results of Southwest Oncology Group trial 9416 (intergroup trial 0160). Proc Am Soc Clin Oncol 22:634,2003,  (abstr 2548)"},{"key":"BIB52","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198805193182004"},{"key":"BIB53","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(98)00429-5"},{"key":"BIB54","doi-asserted-by":"crossref","unstructured":"Komaki R, Scott CB, Byhardt RW, et al: Failure patterns by prognostic group determined by recursive partitioning analysis (RPA) of 1547 patients on four Radiation Therapy Oncology Group studies in inoperable non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 42:263,1988-267,","DOI":"10.1016\/S0360-3016(98)00213-2"},{"key":"BIB55","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.5.1344"},{"key":"BIB56","doi-asserted-by":"publisher","DOI":"10.1097\/00000421-200212000-00011"},{"key":"BIB57","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/83.4.266"},{"key":"BIB58","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(20010615)91:12<2394::AID-CNCR1273>3.0.CO;2-6"},{"key":"BIB59","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1981.03310300023013"},{"key":"BIB60","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19960601)77:11<2393::AID-CNCR31>3.0.CO;2-Q"},{"key":"BIB61","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(20001101)89:9<1946::AID-CNCR10>3.0.CO;2-1"},{"key":"BIB62","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(92)91015-F"},{"key":"BIB63","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.2.622"},{"key":"BIB64","doi-asserted-by":"publisher","DOI":"10.1007\/BF00253278"},{"key":"BIB65","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1999.17.9.2700"},{"key":"BIB66","doi-asserted-by":"crossref","unstructured":"Rusch VW, Griffin BR, Livingston RB: The role of prophylactic cranial irradiation in regionally advanced non-small cell lung cancer. A Southwest Oncology Group Study. J Thorac Cardiovasc Surg 98:535,1989-539,","DOI":"10.1016\/S0022-5223(19)34355-7"},{"key":"BIB67","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(91)90681-S"},{"key":"BIB68","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1992.10.8.1237"},{"key":"BIB69","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/87.3.183"},{"key":"BIB70","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(97)00135-4"},{"key":"BIB71","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(96)00069-7"},{"key":"BIB72","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1985.3.12.1659"}],"container-title":["Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/JCO.2005.03.008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T21:03:00Z","timestamp":1653512580000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/JCO.2005.03.008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5,10]]},"references-count":71,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2005,5,10]]}},"alternative-id":["10.1200\/JCO.2005.03.008"],"URL":"https:\/\/doi.org\/10.1200\/jco.2005.03.008","relation":{},"ISSN":["0732-183X","1527-7755"],"issn-type":[{"value":"0732-183X","type":"print"},{"value":"1527-7755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,5,10]]}}}